Try our Nephrology News tracker. Keep it open and keep tabs on our curated nephrology news feeds

UKidney's Ask the Experts

  1. Guest Doc
  2. Polycystic Kidney Disease
  3. Thursday, February 04 2016, 09:43 AM
  4.  Subscribe via email
I realize that the TEMPO study suggests tolvaptan be used in patients with intact renal function (that is who they enrolled) but have you been using it for later stage CKD as well?

Dr. JS
Responses (1)
Daniel Bichet Accepted Answer
During the TEMPO trial patients with CKD function 1,2 and 3 were enrolled and found to benefit from tolvaptan, that is less kidney enlargment and less deterioration of renal function(as compared to placebo). There were no stage 4 patients, therefore the benefit here is not demonstrated but is presently being tested in an ongoing study (REPRISE).
  1. more than a month ago
  2. Polycystic Kidney Disease
  3. # 1
  • Page :
  • 1

There are no replies made for this post yet.
Be one of the first to reply to this post!
Submit Your Response
Upload files or images for this discussion by clicking on the upload button below. Supports gif,jpg,png,zip,rar,pdf,jpeg,doc,docx,xls,xlsx
• Insert • Remove Upload Files (Maximum File Size: 10 MB)
You may insert polls into your post. The poll would then appear in the post.
Vote Options